ArticlePCN reports : psychiatry and clinical neurosciences2025
The potential role of Saiko-ka-ryukotsu-borei-to in mitigating the severity of anxiety induced by social defeat stress in mice.
Article in PCN reports : psychiatry and clinical neurosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The potential role of Saiko-ka-ryukotsu-borei-to in mitigating the severity of anxiety induced by social defeat stress in mice.PCN reports : psychiatry and clinical neurosciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: Major depressive disorder is a growing global concern with limited treatment options. Social stress contributes to its development, yet pharmacological prevention and mitigation remain underexplored. This study examined the effects of Saiko-ka-ryukotsu-borei-to (SRBT) on depressive and anxiety-like behaviors in mice exposed to social defeat stress (SDS). Methods: C57BL/6J mice were subjected to daily 10-min interactions with larger, more aggressive ICR mice for 10 consecutive days to induce SDS. Immediately following each session, mice were orally administered SRBT, fluoxetine (Flu), or saline (Sal), and were assigned to the SD-SRBT, SD-Flu, and SD-Sal groups, respectively. Mice that received Sal without SDS exposure served as the normal control (NC) group. On the 11th day, behavioral assessments, including the elevated plus maze (EPM) test, tail suspension test (TST), and social interaction test (SIT), were conducted across the four groups. Plasma corticosterone levels were also measured. Results: SDS significantly increased anxiety-like behavior in the EPM, as shown by reduced open arm time in the SD-Sal and SD-Flu groups. This effect was less evident in the SD-SRBT group. Although the SD-Flu group showed similar anxiety-like behavior to the SD-Sal group, no significant difference in open arm time was observed. SDS did not induce social avoidance or depressive-like behavior in the SIT or TST, nor did it alter plasma corticosterone levels. Conclusion: This study suggested that SRBT has the potential to mitigate anxiety caused by social stress. However, further ongoing evaluation and investigation are required to assess the effectiveness of SRBT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.